☆ 4.7 Review

Etiopathogenesis and Emerging Methods for Treatment of Vitiligo

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Related references

Note: Only part of the references are listed.

Article Dermatology

Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial

Khaled Ezzedine et al.

Summary: This study evaluated the efficacy and safety of oral JAK3/TEC inhibitor ritlecitinib in patients with active nonsegmental vitiligo. The results showed that ritlecitinib demonstrated significant efficacy and good tolerability in treating vitiligo.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Current Status of Cell-Based Therapies for Vitiligo

Anna Domaszewska-Szostek et al.

Summary: Vitiligo is a chronic pigmentary disease caused by the destruction of melanocytes, leading to the lack of skin coloration. The treatment of vitiligo aims at repigmentation. This review summarizes the clinical evidence for vitiligo cell-based therapies, considering the procedures, equipment, and effectiveness in repigmentation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Vitiligo, from Pathogenesis to Therapeutic Advances: State of the Art

Federico Diotallevi et al.

Summary: Vitiligo is a condition characterized by acquired hypopigmentation of the skin due to the progressive loss of melanocytes. The exact underlying causes are not well defined, but metabolic abnormalities, oxidative stress, inflammation, and autoimmunity are believed to play a role in the disease. A convergence theory that combines various mechanisms has been proposed to explain the reduction in melanocyte viability. Advances in understanding the pathogenesis of vitiligo have led to the development of more targeted and effective treatments with fewer side effects. This paper provides a narrative review of the literature to examine the pathogenesis and recent treatment options for vitiligo.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Review Dermatology

The possible role of Wnt/β-catenin signalling in vitiligo treatment

Xiran Lin et al.

Summary: Vitiligo is a common chronic skin disease that negatively impacts patients' lives. Its pathogenesis involves autoimmunity and oxidative stress. Treatment should aim to control immune responses and promote melanocyte repigmentation. The Wnt/beta-catenin signalling pathway has emerged as a promising target for vitiligo therapy.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Add to Collection

Review Dermatology

Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors

Kaitlynne N. Cunningham et al.

Summary: Vitiligo is a chronic autoimmune disease causing loss of skin pigmentation, affecting 0.5-2% of the global population. Significant progress has been made in understanding the pathogenesis of vitiligo, which involves a combination of genetics, oxidative stress, inflammation, and environmental triggers. Conventional treatments include camouflage, topical corticosteroids, oral corticosteroids, phototherapy, and surgery, but a new cream targeting the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway has recently been approved by the US FDA for repigmentation in vitiligo patients.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2023)

Add to Collection

Article Dermatology

Excellent Repigmentation of Generalized Vitiligo with Oral Baricitinib Combined with NB-UVB Phototherapy

Xinxin Li et al.

Summary: Vitiligo is an acquired autoimmune skin disorder characterized by white macules and patches resulting from melanocyte destruction. The JAK-STAT pathway plays a crucial role in the loss of epidermal melanocytes. Baricitinib, a JAK1/2 inhibitor, can effectively block this pathway and downstream chemokines. In this report, we describe the successful treatment of 2 patients with oral baricitinib combined with NB-UVB phototherapy, which offers a promising alternative for refractory vitiligo treatment.

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2023)

Add to Collection

Article Dermatology

Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study

Silada Kanokrungsee et al.

Summary: Combination therapy with narrowband ultraviolet B, fractional carbon dioxide laser, and topical bimatoprost 0.01% showed significant advantages in inducing repigmentation and improving vitiligo surface area in non-facial vitiligo patients, compared to dual therapy with NB-UVB and fractional CO2 laser.

DERMATOLOGIC THERAPY (2022)

Add to Collection

Review Dermatology

Therapeutic potential of adipose tissue-derivatives in modern dermatology

Barbara Bellei et al.

Summary: Stem cell-mediated therapies in regenerative medicine, particularly using adipose-derived stem cells and their secretome, have shown promising results in treating various skin disorders.

EXPERIMENTAL DERMATOLOGY (2022)

Add to Collection

Review Cell Biology

The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death

Yijie Xuan et al.

Summary: This review summarizes the role of oxidative stress in the pathogenesis of vitiligo and discusses the mechanisms of interaction between oxidative stress and various modes of cell death. The findings suggest that oxidative stress acts as an initiator for different cell death modes through complex mechanisms, such as autophagy, apoptosis, and ferroptosis. These insights provide new ideas for exploring the pathogenesis and potential therapeutic targets of vitiligo.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Add to Collection

Article Pharmacology & Pharmacy

Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro

Jie Dong et al.

Summary: In this study, we found that baricitinib was effective and safe in treating patients with progressing vitiligo. In vitro experiments showed that baricitinib could promote tyrosinase activity, melanin content, and TYR, TRP-1 gene expression of melanocytes.

DOSE-RESPONSE (2022)

Add to Collection

Letter Dermatology

Efficacy of ruxolitinib cream in vitiligo by patient characteristics and affected body areas: Descriptive subgroup analyses from a phase 2, randomized, double-blind trial

Iltefat Hamzavi et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)

Add to Collection

Article Dermatology

Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy

Patrick O. Perche et al.

Summary: Oral tofacitinib has become increasingly utilized for immune-mediated skin conditions, and there are a few case reports showing its efficacy in treating patients with both alopecia areata and vitiligo.

JOURNAL OF DRUGS IN DERMATOLOGY (2022)

Add to Collection

Article Dermatology

Assessment of prostaglandin F2-alpha (PGF2α) in lesional and nonlesional skin of vitiligo patients

Noha A. Nagui et al.

Summary: This study investigated the potential role of PGF2 alpha in the pathogenesis of vitiligo and found that the tissue levels of PGF2 alpha were significantly higher in both lesional and nonlesional skin of vitiligo patients compared to healthy controls. The findings suggest that PGF2 alpha may be implicated in the development of vitiligo.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2022)

Add to Collection

Letter Dermatology

Addition of Narrow-Band UVB Phototherapy to Ruxolitinib Cream in Patients With Vitiligo

Amit G. Pandya et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

David Rosmarin et al.

Summary: In two phase 3 trials, ruxolitinib cream showed greater repigmentation of vitiligo lesions compared to a vehicle control. However, it was associated with acne and pruritus at the application site.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Damage-associated molecular patterns in vitiligo: igniter fuse from oxidative stress to melanocyte loss

Jingying Wang et al.

Summary: Oxidative stress may play a key role in vitiligo pathogenesis, with DAMPs being crucial in inducing immune responses. Targeting DAMPs in treatment regimens can effectively improve disease severity.

REDOX REPORT (2022)

Add to Collection

Review Immunology

Advances in vitiligo: Update on therapeutic targets

Yifei Feng et al.

Summary: This paper provides a synopsis of current practices in vitiligo treatment and introduces the progress in identifying new molecular targets and applying molecular-targeted therapies, offering valuable insights for establishing further precision medicine for vitiligo patients.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection

Review Dermatology

Role of HMGB1 in Vitiligo: Current Perceptions and Future Perspectives

Guangmin Wei et al.

Summary: Vitiligo is a chronic depigmenting disorder caused by the destruction of epidermal melanocytes, with oxidative stress playing a key role in its pathogenesis. HMGB1, a nonhistone protein, is overexpressed in vitiligo patients and may participate in the pathological process triggered by oxidative stress. Studying the role of HMGB1 could provide new insights into vitiligo pathogenesis and treatment strategies.

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2022)

Add to Collection

Article Dermatology

Simvastatin and non-segmental vitiligo: A new potential treatment option?

Engi Seif E. Shaker et al.

Summary: This study is the first to consider the correlation between lipid disturbances and vitiligo disease activity. The results demonstrate that simvastatin can improve lipid profile and reduce vitiligo activity in patients with non-segmental vitiligo and dyslipidemia.

DERMATOLOGIC THERAPY (2022)

Add to Collection

Article Dermatology

Clinical outcomes of topical bimatoprost for nonsegmental facial vitiligo: A preliminary study

Silada Kanokrungsee et al.

Summary: This study compared the efficacy and safety of 0.01% bimatoprost solution with 0.1% tacrolimus ointment in treating patients with nonsegmental facial vitiligo. The results showed that bimatoprost solution was safe and effective for repigmentation, with comparable results to tacrolimus ointment, making it a potential alternative treatment option for facial vitiligo.

JOURNAL OF COSMETIC DERMATOLOGY (2021)

Add to Collection

Article Dermatology

A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo

Yomna Mazid El-Hamd Neinaa et al.

Summary: The combination of latanoprost with microneedling and NB-UVB phototherapy shows more significant therapeutic outcomes in treating stable nonsegmental vitiligo, enhancing the degree of repigmentation.

DERMATOLOGIC THERAPY (2021)

Add to Collection

Review Immunology

Janus Kinase Inhibitors in the Treatment of Vitiligo: A Review

Fei Qi et al.

Summary: Vitiligo is a reversible skin disorder characterized by white patches resulting from destruction of melanocytes. JAK inhibitors have shown effectiveness in treating vitiligo by targeting the JAK/STAT pathway, but further studies are needed to determine optimal dosage and identify other inflammatory pathways involved in the pathogenesis of the condition.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection

Article Cell Biology

Clinical Significance of Serum Oxidative Stress Markers to Assess Disease Activity and Severity in Patients With Non-Segmental Vitiligo

Shuli Li et al.

Summary: This study found dysregulated oxidative stress status in patients with non-segmental vitiligo (NSV), with antioxidant enzymes, total antioxidant capacity, and oxidative biomarkers showing significant differences compared to healthy controls. These serum markers were correlated with disease activity and severity, indicating their potential for assessing the condition in NSV patients.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Allergy

Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Polish

Tomasz Iwanowski et al.

Summary: The study aimed to translate, cross-culturally adapt, and validate the Vitiligo-specific health-related quality of life instrument (VitiQoL) into Polish. Results showed significant correlations between VitiQoL and DLQI, as well as between VitiQoL-PL and subjects' assessment of the severity of their disease. A specific index for estimating quality of life of patients with vitiligo in Poland was validated and implemented through an online survey.

POSTEPY DERMATOLOGII I ALERGOLOGII (2021)

Add to Collection

Letter Dermatology

Afamelanotide implants and narrow-band ultraviolet B phototherapy for the treatment of nonsegmental vitiligo in Asians

Joseph Jia Hong Toh et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Add to Collection

Article Cell Biology

ROS and diseases: role in metabolism and energy supply

Shenshu Yang et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)

Add to Collection

Article Dermatology

Partial repigmentation of vitiligo with tofacitinib, without exposure to ultraviolet radiation

Melpone Komnitski et al.

ANAIS BRASILEIROS DE DERMATOLOGIA (2020)

Add to Collection

Letter Dermatology

New onset vitiligo in a patient with hidradenitis suppurativa treated with adalimumab

Kevin Phan et al.

DERMATOLOGIC THERAPY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The Role of TRM Cells in the Pathogenesis of Vitiligo-A Review of the Current State-Of-The-Art

Alicja Fraczek et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Nanoscience & Nanotechnology

Recent Progress and Future Directions: The Nano-Drug Delivery System for the Treatment of Vitiligo

Ming-Chen Sun et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Add to Collection

Letter Dermatology

Repigmentation of vitiligo with oral baricitinib

Blake P. Mumford et al.

AUSTRALASIAN JOURNAL OF DERMATOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

David Rosmarin et al.

LANCET (2020)

Add to Collection

Review Dermatology

Vitiligo, From Physiopathology to Emerging Treatments: A Review

Laure Migayron et al.

DERMATOLOGY AND THERAPY (2020)

Add to Collection

Review Cell Biology

The Hsp70 chaperone network

Rina Rosenzweig et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)

Add to Collection

Article Allergy

Efficacy of suction blister epidermal grafting with concomitant phototherapy in vitiligo treatment

Tomasz Iwanowski et al.

POSTEPY DERMATOLOGII I ALERGOLOGII (2018)

Add to Collection

Article Dermatology

Bimatoprost ophthalmic solution in facial vitiligo

Abhijeet K. Jha et al.

JOURNAL OF COSMETIC DERMATOLOGY (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Steven J. Forrester et al.

CIRCULATION RESEARCH (2018)

Add to Collection

Review Physiology

Role of ROS and Nutritional Antioxidants in Human Diseases

Zewen Liu et al.

FRONTIERS IN PHYSIOLOGY (2018)

Add to Collection

Review Immunology

Tissue-Resident Memory CD8+ T Cells: From Phenotype to Function

David J. Topham et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Review Immunology

Resident-Memory T Cells in Tissue-Restricted Immune Responses: For Better or Worse?

Karin Steinbach et al.

FRONTIERS IN IMMUNOLOGY (2018)

Add to Collection

Article Dermatology

New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases

L. Mery-Bossard et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)

Add to Collection

Article Dermatology

Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis

Ronghua Li et al.

PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2017)

Add to Collection

Letter Medicine, General & Internal

New onset vitiligo following commencement of infliximab in Crohn disease

Raphael P. Luber et al.

INTERNAL MEDICINE JOURNAL (2017)

Add to Collection

Review Dermatology

Current and emerging treatments for vitiligo

Michelle Rodrigues et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Add to Collection

Letter Dermatology

A double-blind, placebo-controlled, phase-II clinical trial to evaluate oral simvastatin as a treatment for vitiligo

Stefan G. Vanderweil et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)

Add to Collection

Article Medicine, Research & Experimental

Ruxolitinib-conjugated gold nanoparticles for topical administration: An alternative for treating alopecia?

Sanda Boca et al.

MEDICAL HYPOTHESES (2017)

Add to Collection

Review Pharmacology & Pharmacy

Pharmacokinetics and Pharmacodynamics of Afamelanotide and its Clinical Use in Treating Dermatologic Disorders

Elisabeth I. Minder et al.

CLINICAL PHARMACOKINETICS (2017)

Add to Collection

Article Dermatology

Inflammasomes and dermatology

Daniel Coelho de Sa et al.

ANAIS BRASILEIROS DE DERMATOLOGIA (2016)

Add to Collection

Article Dermatology

Increased expression of CXCR3 and its ligands in patients with vitiligo and CXCL10 as a potential clinical marker for vitiligo

X. X. Wang et al.

BRITISH JOURNAL OF DERMATOLOGY (2016)

Add to Collection

Article Dermatology

A pilot comparative study of topical latanoprost and tacrolimus in combination with narrow-band ultraviolet B phototherapy and microneedling for the treatment of nonsegmental vitiligo

Igor V. Korobko et al.

DERMATOLOGIC THERAPY (2016)

Add to Collection

Article Dermatology

The Vitiligo Impact Patient Scale (VIPs): Development and Validation of a Vitiligo Burden Assessment Tool

Camille Salzes et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)

Add to Collection

Letter Dermatology

Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)

John E. Harris et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)

Add to Collection

Article Genetics & Heredity

Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants

Ying Jin et al.

NATURE GENETICS (2016)

Add to Collection

Article Multidisciplinary Sciences

The Prevalence of Vitiligo: A Meta-Analysis

Yuhui Zhang et al.

PLOS ONE (2016)

Add to Collection

Article Dermatology

Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo

Lili Yang et al.

ACTA DERMATO-VENEREOLOGICA (2015)

Add to Collection

Article Medicine, General & Internal

Vitiligo

Khaled Ezzedine et al.

LANCET (2015)

Add to Collection

Article Dermatology

Afamelanotide and Narrowband UV-B Phototherapy for the Treatment of Vitiligo A Randomized Multicenter Trial

Henry W. Lim et al.

JAMA DERMATOLOGY (2015)

Add to Collection

Article Dermatology

Tofacitinib Citrate for the Treatment of Vitiligo A Pathogenesis-Directed Therapy

Brittany G. Craiglow et al.

JAMA DERMATOLOGY (2015)

Add to Collection

Article Dermatology

The effect of latanoprost on vitiligo: a preliminary comparative study

Tag S. Anbar et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2015)

Add to Collection

Article Hematology

Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack

Jamie A. Lopez et al.

BLOOD (2013)

Add to Collection

Article Genetics & Heredity

Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo

Ying Jin et al.

NATURE GENETICS (2012)

Add to Collection

Article Medicine, General & Internal

Variant of TYR and Autoimmunity Susceptibility Loci in Generalized Vitiligo.

Ying Jin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Add to Collection

Article Dermatology

The burden of vitiligo: Patient characteristics associated with quality of life

May W. Linthorst Homan et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)

Add to Collection

Article Dermatology

Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China

Xiukun Sun et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2006)

Add to Collection

Review Public, Environmental & Occupational Health

Markers of genetic susceptibility in human environmental hygiene and toxicology:: The role of selected CYP, NAT and GST genes

R Thier et al.

INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2003)

Add to Collection

Article Cell Biology

Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families

A Alkhateeb et al.

PIGMENT CELL RESEARCH (2003)

Add to Collection

Article Dermatology

Topical prostaglandin analog (PGE2) in vitiligo -: a preliminary study

D Parsad et al.

INTERNATIONAL JOURNAL OF DERMATOLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.